SG/CALL/EDWARDS LIFESCIENCES/95/0.1/20.09.24 | Market Closed - Boerse Frankfurt Warrants 15:38:07 2024-07-03 EDT | ||
| 0.42 EUR | -6.67% |
|
| Current month | -20.75% | ||
| 1 month | -16.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-03 | 0.42 | -6.67% |
| 24-07-02 | 0.45 | +7.14% |
| 24-07-01 | 0.42 | -20.75% |
| 24-06-28 | 0.53 | -10.17% |
| 24-06-27 | 0.59 | +18.00% |
Real-time Boerse Frankfurt Warrants
Last update July 03, 2024 at 03:38 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SU6C24 |
| ISIN | DE000SU6C248 |
| Date issued | 2023-12-28 |
| Strike | 95 $ |
| Maturity | 2024-09-20 (79 Days) |
| Parity | 10 : 1 |
| Emission price | 0.67 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.28 € |
|---|---|
| Lowest since issue | 0.37 € |
| Spread | 0.06 € |
| Spread % | 12.50% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.08
USD
Average target price
96.13
USD
Spread / Average Target
+5.54%
- Stock Market
- Warrants
- Warrant
